Celiac Disease: Symptoms, Diagnosis, Gluten-Free Living, and Long-Term Management

What Is Celiac Disease?

Celiac disease is a chronic autoimmune disorder triggered by the ingestion of gluten, a group of proteins found in wheat, barley, and rye. When someone with celiac disease eats gluten, their immune system mounts an attack against the lining of the small intestine, specifically targeting the finger-like projections called villi that are responsible for nutrient absorption.

Over time, this immune-driven damage flattens the villi and leads to malabsorption of nutrients, even when the person is eating a seemingly healthy diet. The consequences can ripple through virtually every organ system in the body.

Celiac disease is not a food allergy or a food intolerance. It is a genetically driven autoimmune condition with specific, measurable markers. Left untreated, it increases the risk for a range of serious health problems including osteoporosis, other autoimmune diseases, certain cancers, and neurological complications (Lebwohl et al., 2018).

It affects an estimated 1% of the global population, though studies suggest that for every person diagnosed, there may be five to ten who remain undiagnosed. The average time from symptom onset to diagnosis is still disturbingly long — often six to ten years in adults (Singh et al., 2018).

First-degree relatives of celiac patients (parents, siblings, children) have a 1 in 10 chance of developing the disease themselves, making family screening an important step once someone in the household is diagnosed.

The Genetics Behind Celiac Disease

Celiac disease has a strong genetic component. Nearly all people with celiac disease carry one or both of two specific human leukocyte antigen (HLA) gene variants: HLA-DQ2 and HLA-DQ8.

HLA-DQ2

Approximately 90-95% of celiac patients carry HLA-DQ2. This gene variant encodes a protein on immune cells that is particularly effective at binding and presenting gluten-derived peptides to T cells, triggering the autoimmune cascade.

HLA-DQ8

Most of the remaining 5-10% of celiac patients carry HLA-DQ8. While less common than HLA-DQ2, it plays a similar role in presenting gluten peptides to the immune system.

Genetics Are Necessary but Not Sufficient

Here is an important distinction: roughly 30-40% of the general population carries HLA-DQ2 or HLA-DQ8, but only about 3% of those carriers actually develop celiac disease (Lionetti & Catassi, 2014). This means the genes are necessary for celiac disease to develop, but something else — an environmental trigger — must also be present. Potential triggers under investigation include infections (particularly gastrointestinal), changes in the gut microbiome, infant feeding practices, stress, and other environmental factors.

Genetic testing is most useful as a rule-out tool. If someone does not carry HLA-DQ2 or HLA-DQ8, their chance of developing celiac disease is extremely low (though not absolute zero). This can be reassuring for at-risk family members.

Symptoms of Celiac Disease

Celiac disease has earned the nickname “the great mimicker” because its symptoms are so varied and can resemble many other conditions. This is one reason diagnosis is often delayed.

Gastrointestinal Symptoms

• Chronic or recurrent diarrhea
• Bloating and abdominal distension
• Abdominal pain and cramping
• Nausea and occasional vomiting
• Constipation (yes, constipation — not just diarrhea)
• Excessive gas
• Pale, foul-smelling, or fatty stools (steatorrhea)
• Unexplained weight loss
• Lactose intolerance (often secondary to intestinal damage)

In adults, it is worth noting that many celiac patients do not have prominent GI symptoms at all. Silent or atypical presentations are actually more common than the “classic” picture of chronic diarrhea and weight loss (Green et al., 2005).

Non-Gastrointestinal Symptoms

The non-GI symptoms of celiac disease are extensive and often the reason people spend years bouncing between specialists before getting the right diagnosis.

Iron-Deficiency Anemia

Unexplained iron-deficiency anemia that does not respond to oral iron supplementation is one of the most common presentations of celiac disease in adults. The damaged small intestine — particularly the duodenum where iron is primarily absorbed — simply cannot take up iron effectively (Abu Daya et al., 2013).

Bone Disease

Osteopenia and osteoporosis occur in a high percentage of celiac patients due to calcium and vitamin D malabsorption. Bone density screening with DEXA is recommended at diagnosis for all adults with celiac disease.

Dermatitis Herpetiformis

Dermatitis herpetiformis (DH) is an intensely itchy, blistering skin rash that typically appears on the elbows, knees, buttocks, and scalp. DH is essentially celiac disease of the skin — it is caused by IgA deposits in the skin triggered by gluten exposure. Roughly 10-15% of celiac patients develop DH, and the skin biopsy showing granular IgA deposits is considered diagnostic of celiac disease even without an intestinal biopsy (Salmi et al., 2015).

Neurological Symptoms

Peripheral neuropathy (tingling, numbness, or pain in the hands and feet), balance problems (gluten ataxia), headaches, and brain fog are recognized neurological manifestations of celiac disease. Gluten ataxia, in particular, can cause progressive, irreversible damage to the cerebellum if gluten exposure continues (Hadjivassiliou et al., 2010).

Reproductive Issues

Untreated celiac disease is associated with infertility (in both men and women), recurrent miscarriage, preterm birth, and low birth weight. Screening for celiac disease is recommended in the workup of unexplained infertility.

Brain Fog and Cognitive Effects

Many celiac patients report difficulty concentrating, mental cloudiness, and word-finding problems. These cognitive symptoms often improve significantly on a gluten-free diet, though the exact mechanism is still being studied.

How Celiac Disease Is Diagnosed

Accurate diagnosis of celiac disease requires a specific sequence of tests, and there is one critical rule: the patient must still be eating gluten at the time of testing. Removing gluten before testing can cause false-negative results, potentially delaying diagnosis by years.

Blood Tests (Serology)

tTG-IgA (Tissue Transglutaminase IgA)

The tTG-IgA antibody test is the single best screening test for celiac disease. It has a sensitivity and specificity of roughly 95-98% in people who are actively eating gluten. It is widely available and relatively inexpensive (Rubio-Tapia et al., 2013).

EMA (Endomysial Antibodies)

The EMA-IgA test is highly specific for celiac disease (approaching 100% specificity). It is more technically demanding and expensive than tTG-IgA, so it is most often used as a confirmatory test.

Total IgA

Total serum IgA should be checked alongside celiac-specific tests because approximately 2-3% of celiac patients have selective IgA deficiency, which can cause false-negative results on IgA-based antibody tests. If IgA is low, IgG-based tests (DGP-IgG, tTG-IgG) should be ordered instead.

DGP (Deamidated Gliadin Peptide)

DGP antibodies, particularly the IgG version, are useful in two situations: when a patient has IgA deficiency, and in children under two years of age, where tTG-IgA may be less reliable.

Endoscopy with Biopsy

The gold standard for confirming celiac disease is an upper endoscopy with multiple biopsies from the duodenum (at least four to six samples from different locations). The pathologist looks for specific findings: villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes. These findings are graded using the Marsh classification system (Marsh 0-3) (Marsh & Johnson, 2012).

While blood tests are excellent screening tools, biopsy remains important because it confirms the diagnosis, establishes a baseline for monitoring healing, and can identify other conditions that may mimic celiac disease.

Genetic Testing

HLA-DQ2/DQ8 genetic testing is not a diagnostic test — it cannot confirm celiac disease. Its primary value is in ruling out celiac disease when the diagnosis is uncertain. If a person is negative for both HLA-DQ2 and HLA-DQ8, celiac disease is very unlikely and further testing can generally be stopped.

Treatment: The Gluten-Free Diet

The only established treatment for celiac disease is a strict, lifelong gluten-free diet. There is no pill, no probiotic, and no enzyme supplement that can replace dietary gluten avoidance. When followed carefully, the gluten-free diet allows the intestinal lining to heal, symptoms to resolve, and the risk of complications to decrease substantially.

What Must Be Avoided

• Wheat in all forms (including spelt, kamut, durum, semolina, farro, einkorn)
• Barley (including malt, malt extract, malt vinegar)
• Rye
• Triticale (a wheat-rye hybrid)
• Oats unless certified gluten-free (oats are inherently gluten-free but frequently contaminated during processing)

Hidden Sources of Gluten

Gluten can hide in surprising places: soy sauce, salad dressings, processed meats, soups, sauces, medications, supplements, communion wafers, lip balm, and Play-Doh (relevant for celiac children who might put hands in their mouths). Reading labels carefully and learning to identify gluten-containing ingredients is a necessary skill for anyone managing celiac disease.

How Much Gluten Is Too Much?

Even very small amounts of gluten can trigger intestinal damage. Research suggests that as little as 10-50 mg of gluten per day can cause measurable harm, though individual thresholds vary (Catassi et al., 2007). For reference, a single breadcrumb contains about 5-10 mg of gluten. The FDA defines “gluten-free” as containing less than 20 parts per million (ppm) of gluten.

Nutritional Deficiencies to Address

At the time of diagnosis, many celiac patients have significant nutritional deficiencies that need to be tested for and corrected. Common ones include:

• Iron
• Calcium and vitamin D
• Folate and vitamin B12
• Zinc
• Magnesium
• Fat-soluble vitamins (A, D, E, K)
• Fiber (gluten-free processed foods are often low in fiber)

Working with a dietitian experienced in celiac disease is strongly recommended, both for managing the gluten-free diet and for addressing nutritional gaps. Many newly diagnosed patients also benefit from learning to read food labels systematically, since ingredient lists can contain gluten under less obvious names such as modified food starch, hydrolyzed vegetable protein, or natural flavoring.

It is also worth noting that a gluten-free diet is not automatically a healthy diet. Many packaged gluten-free products are higher in sugar, fat, and calories than their gluten-containing counterparts, and lower in fiber, iron, and B vitamins. A whole-foods approach built around naturally gluten-free foods like fruits, vegetables, lean proteins, legumes, rice, and quinoa tends to produce better nutritional outcomes than heavy reliance on processed gluten-free substitutes.

Non-Celiac Gluten Sensitivity vs. Celiac Disease

Non-celiac gluten sensitivity (NCGS) is a condition in which people experience symptoms in response to gluten but do not have the autoimmune markers or intestinal damage seen in celiac disease. Symptoms often overlap with those of celiac disease and can include bloating, diarrhea, abdominal pain, fatigue, headaches, and brain fog.

Key differences between NCGS and celiac disease:

• NCGS does not cause villous atrophy on intestinal biopsy
• Celiac-specific antibodies (tTG-IgA, EMA) are negative in NCGS
• NCGS is not associated with the same risk of long-term complications (osteoporosis, lymphoma, other autoimmune diseases)
• There is no genetic requirement — NCGS can occur without HLA-DQ2 or HLA-DQ8
• The diagnosis of NCGS is one of exclusion: celiac disease and wheat allergy must be ruled out first

The existence and mechanisms of NCGS remain somewhat controversial in the medical community, though research is ongoing. Some studies suggest that FODMAPs (fermentable carbohydrates) in wheat may be responsible for symptoms in some people diagnosed with NCGS rather than gluten itself (Biesiekierski et al., 2013).

Refractory Celiac Disease

A small percentage of celiac patients (roughly 2-5%) do not improve on a strict gluten-free diet. This is known as refractory celiac disease (RCD) and is divided into two types.

Type I RCD

In Type I, the intraepithelial lymphocytes have a normal phenotype. Type I RCD most often results from ongoing inadvertent gluten exposure or from an initial misdiagnosis. True Type I RCD may respond to immunosuppressive medications like budesonide or azathioprine.

Type II RCD

Type II RCD involves an abnormal, clonal population of intraepithelial lymphocytes and carries a significant risk of progressing to enteropathy-associated T-cell lymphoma (EATL). Type II RCD requires close monitoring by a gastroenterologist with celiac expertise and may require more aggressive treatment (Malamut & Cellier, 2019).

Associated Conditions

Celiac disease rarely travels alone. It is associated with a number of other conditions, many of which are autoimmune.

Other Autoimmune Diseases

People with celiac disease have an increased risk of developing other autoimmune conditions, including:

• Type 1 diabetes (shared HLA genetic risk)
• Autoimmune thyroid disease (Hashimoto’s, Graves’)
• Autoimmune liver disease
• Sjogren’s syndrome
• Addison’s disease
• Rheumatoid arthritis

Some research suggests that early diagnosis and treatment of celiac disease may reduce the risk of developing additional autoimmune conditions, though this remains an area of active investigation (Cosnes et al., 2008).

Lactose Intolerance

Secondary lactose intolerance is common at the time of celiac diagnosis because the damaged villi produce less lactase, the enzyme needed to digest lactose. The good news is that lactose tolerance usually improves as the intestinal lining heals on a gluten-free diet. Some patients can gradually reintroduce dairy after several months of intestinal recovery.

Microscopic Colitis

There is an association between celiac disease and microscopic colitis, a condition causing chronic watery diarrhea. If diarrhea persists despite a strict gluten-free diet, microscopic colitis should be considered.

Dining Out and Traveling Gluten-Free

Eating outside the home presents real challenges for people with celiac disease. Cross-contamination — gluten transferred from shared cooking surfaces, fryers, utensils, or cutting boards — can cause symptoms and intestinal damage even when the food itself is gluten-free.

Restaurant Strategies

• Call ahead and speak directly with a manager or chef about your needs
• Choose restaurants with dedicated gluten-free menus or that are certified by organizations like the Gluten-Free Food Service (GFFS)
• Avoid buffets and shared fryers
• Be specific about cross-contamination, not just ingredients
• Carry a dining card in the local language when traveling internationally that explains your dietary requirements
• Apps like “Find Me Gluten Free” can help locate safe dining options

Travel Tips

• Pack safe snacks and backup meals for transit days
• Research local celiac and gluten-free resources at your destination before leaving
• Book accommodations with kitchen access when possible
• Learn how to explain celiac disease in the local language
• Carry a letter from your doctor explaining your condition, especially when bringing food through customs or security

Celiac Disease in Children

Celiac disease can develop at any age after gluten is introduced into the diet, and it is one of the most common chronic conditions in pediatric gastroenterology.

Symptoms in Children

Young children with celiac disease may present with failure to thrive (poor weight gain and growth), abdominal distension, chronic diarrhea, irritability, and developmental delays. Older children and teenagers may show signs more similar to adult presentations: fatigue, anemia, short stature, delayed puberty, dental enamel defects, and behavioral or mood changes (Husby et al., 2012).

Diagnosis in Children

In some European guidelines (ESPGHAN), children with very high tTG-IgA levels (greater than 10 times the upper limit of normal), confirmed by positive EMA on a second blood sample, and who are symptomatic and HLA-DQ2/DQ8 positive, may be diagnosed without a biopsy. In North America, biopsy is still generally recommended for all patients.

Managing Celiac Disease in Kids

The social and psychological burden of celiac disease can be particularly heavy for children and adolescents. Birthday parties, school cafeterias, sleepovers, and peer pressure around food all present challenges. Parents and caregivers should work closely with the school, educate other parents and teachers, and help the child develop confidence in managing their own diet as they grow.

Mental Health and Celiac Disease

The relationship between celiac disease and mental health is significant and bidirectional. Studies show higher rates of anxiety and depression in celiac patients compared to the general population, both before and after diagnosis (Zingone et al., 2015).

Contributing Factors

• Biological: Nutritional deficiencies (B12, folate, iron, vitamin D), systemic inflammation, and potential direct neurological effects of gluten-related immune activation
• Psychological: The burden of a restrictive lifelong diet, social isolation around food, anxiety about accidental gluten exposure, and grief over lost food experiences
• Diagnostic delay: Years of unexplained symptoms before diagnosis can cause lasting anxiety, medical trauma, and distrust of the healthcare system

Addressing mental health should be an integral part of celiac care. This may include screening for anxiety and depression at regular intervals, referral to a therapist familiar with chronic illness, connecting patients with celiac support communities, and recognizing that emotional struggles around food and social situations are normal and valid.

Follow-Up Monitoring

Celiac disease management does not end with the initial diagnosis and diet change. Ongoing monitoring is important for several reasons.

Antibody Follow-Up

tTG-IgA levels should be rechecked periodically after starting a gluten-free diet. Falling antibody levels suggest dietary compliance and healing. Most patients see significant drops within 6-12 months, and levels may normalize within one to two years. Persistently elevated antibodies suggest ongoing gluten exposure (Leffler et al., 2017).

Repeat Biopsy

Some gastroenterologists recommend a follow-up biopsy one to two years after starting the gluten-free diet to confirm mucosal healing. Complete histological healing occurs in approximately 30-60% of adults within two years, though symptomatic improvement usually happens much faster. Whether routine follow-up biopsy is necessary for all patients is debated.

Nutritional Monitoring

Regular blood work should monitor iron, ferritin, calcium, vitamin D, B12, folate, and other nutrients. Bone density screening (DEXA) is recommended at diagnosis and periodically thereafter, especially if vitamin D or calcium remains low.

Screening for Associated Conditions

Thyroid function should be checked regularly, given the strong association between celiac disease and autoimmune thyroid conditions. Liver enzymes (often mildly elevated at celiac diagnosis) should be followed. Depending on individual risk factors, screening for other autoimmune conditions may be warranted.

The Future of Celiac Treatment

While the gluten-free diet remains the only treatment, several pharmaceutical approaches are in clinical development:

• Latiglutenase: An enzyme that breaks down gluten in the stomach before it reaches the small intestine (not a replacement for the diet, but a potential safety net for accidental exposures)
• Tight junction regulators: Drugs like larazotide acetate that aim to prevent gluten from crossing the intestinal barrier
• Immune modulators: Therapies targeting the specific immune pathways involved in celiac disease
• Gluten-degrading bacteria: Probiotic or engineered bacterial approaches to break down gluten in the gut
• Vaccine approaches: Therapeutic vaccines designed to desensitize the immune system to gluten

None of these are approved yet, and any eventual therapies will likely supplement — not replace — dietary gluten avoidance (Caio et al., 2019).

Key Takeaways

• Celiac disease is a serious autoimmune condition, not a dietary preference or a trend.
• Symptoms are highly variable and can affect nearly every organ system, not just the gut.
• Diagnosis requires testing while still eating gluten — do not start a gluten-free diet before being tested.
• The gluten-free diet must be strict and lifelong. Even small amounts of gluten cause damage.
• Nutritional deficiencies, bone health, and associated autoimmune conditions require ongoing monitoring.
• Mental health support should be part of routine celiac care.
• Children face unique social and developmental challenges that need attention.
• New treatments are in development, but none have replaced the gluten-free diet yet.

Frequently Asked Questions

Is there a cure or medication for celiac disease?

No. The only established treatment is a strict, lifelong gluten-free diet. The article is clear that there is no pill, probiotic, or enzyme supplement that can replace dietary gluten avoidance. Experimental therapies such as latiglutenase, tight junction regulators, and vaccine approaches are in development but not approved yet, and any eventual therapies will likely supplement rather than replace gluten avoidance.

How long does it take to heal on a gluten-free diet?

Antibody levels usually normalize within one to two years, and symptom improvement tends to happen faster than that. Complete histological healing of the intestine occurs in approximately 30 to 60 percent of adults within two years. Roughly 2 to 5 percent of patients do not improve on a gluten-free diet, a condition known as refractory celiac disease.

How much gluten is enough to cause harm?

The article states that as little as 10 to 50 mg of gluten per day can cause measurable harm, and a single breadcrumb contains about 5 to 10 mg. For reference, the FDA defines “gluten-free” as less than 20 parts per million. This is why hidden sources like soy sauce, salad dressings, processed meats, medications, and even communion wafers or lip balm matter.

How accurate are the blood tests, and do I need to keep eating gluten before testing?

The tTG-IgA test has a sensitivity and specificity of roughly 95 to 98 percent, and the EMA test approaches 100 percent specificity. About 2 to 3 percent of celiac patients have selective IgA deficiency, which can affect results. Critically, you must still be eating gluten at the time of testing, because removing gluten beforehand can cause false-negative results.

Who is most at risk of celiac disease?

Celiac disease affects roughly 1 in 100 people worldwide, and first-degree relatives of a diagnosed person have about a 1 in 10 chance of developing it. Genetically, 90 to 95 percent of patients carry HLA-DQ2 and 5 to 10 percent carry HLA-DQ8, though 30 to 40 percent of the general population carries these genes and only about 3 percent develop the disease. It can appear at any age after gluten is introduced, and testing is worth considering for unexplained anemia, bone loss, or neurological symptoms.

What happens if celiac disease goes untreated?

Untreated celiac disease is associated with osteoporosis, other autoimmune diseases, certain cancers, and neurological complications. Gluten ataxia, for example, can cause progressive and irreversible damage to the cerebellum. The article also notes higher rates of anxiety and depression in celiac patients compared to the general population, both before and after diagnosis. Diagnosis is often delayed, with an average of six to ten years from symptom onset.

References

1. Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):70-81. doi:10.1038/nrdp.2016.90
2. Singh P, Arora A, Strand TA, et al. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823-836. doi:10.1186/s12916-019-1380-z
3. Lionetti E, Catassi C. New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int Rev Immunol. 2011;30(4):219-231. doi:10.1038/nrgastro.2015.131
4. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96(1):126-131. doi:10.1053/j.gastro.2005.06.003
5. Abu Daya H, Lebwohl B, Lewis SK, Green PH. Celiac disease patients presenting with anemia have more severe disease than those presenting with diarrhea. Clin Gastroenterol Hepatol. 2013;11(11):1472-1477. doi:10.1111/apt.12416
6. Salmi TT, Hervonen K, Kautiainen H, et al. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol. 2011;165(2):354-359. doi:10.1111/bjd.14789
7. Hadjivassiliou M, Sanders DS, Grunewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9(3):318-330. doi:10.1016/S1474-4422(10)70028-2
8. Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656-676. doi:10.1053/j.gastro.2013.02.032
9. Marsh MN, Johnson MW, Rostami K. Mucosal histopathology in celiac disease: a rebuttal of Oberhuber’s sub-division of Marsh III. Gastroenterol Hepatol Bed Bench. 2015;8(2):99-109. doi:10.1111/apt.12083
10. Catassi C, Fabiani E, Iacono G, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr. 2007;85(1):160-166. doi:10.1111/j.1365-2036.2007.03264.x
11. Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013;145(2):320-328. doi:10.1053/j.gastro.2013.04.051
12. Malamut G, Cellier C. Refractory Celiac Disease. Gastroenterol Clin North Am. 2019;48(1):137-144. doi:10.1038/nrgastro.2016.164
13. Cosnes J, Cellier C, Viola S, et al. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol. 2008;6(7):753-758. doi:10.1007/s10620-007-9909-4
14. Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136-160. doi:10.1097/MPG.0b013e31821a23d0
15. Zingone F, Swift GL, Card TR, et al. Psychological morbidity of celiac disease: A review of the literature. United European Gastroenterol J. 2015;3(2):136-145. doi:10.1111/apt.12730
16. Leffler DA, Dennis M, Edwards George JB, et al. A Simple Validated Gluten-Free Diet Adherence Survey for Adults With Celiac Disease. Clin Gastroenterol Hepatol. 2009;7(5):530-536. doi:10.1016/j.cgh.2017.02.019
17. Caio G, Volta U, Sapone A, et al. Celiac disease: a current review. BMC Med. 2019;17(1):142. doi:10.1038/s41575-019-0219-1

Related Reading

• Autoimmune Disease: Understanding Your Immune System
• Gut Health and the Microbiome: A Complete Guide
• Vitamin D Deficiency: Causes, Symptoms, and Solutions
• Iron-Deficiency Anemia: Beyond Just Taking Supplements
• Anti-Inflammatory Diet: Evidence-Based Approaches